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Transcriptional control of hematopoiesis involves complex regulatory networks and
functional perturbations in one of these components often results in malignancies. Loss-
of-function mutations in PHF6, encoding a presumed epigenetic regulator, have been
primarily described in T cell acute lymphoblastic leukemia (T-ALL) and the first insights
into its function in normal hematopoiesis only recently emerged from mouse modeling
experiments. Here, we investigated the role of PHF6 in human blood cell development
by performing knockdown studies in cord blood and thymus-derived hematopoietic
precursors to evaluate the impact on lineage differentiation in well-established in vitro
models. Our findings reveal that PHF6 levels differentially impact the differentiation of
human hematopoietic progenitor cells into various blood cell lineages, with prominent
effects on lymphoid and erythroid differentiation. We show that loss of PHF6 results in
accelerated human T cell development through reduced expression of NOTCH1 and
its downstream target genes. This functional interaction in developing thymocytes was
confirmed in vivo using a phf6-deficient zebrafish model that also displayed accelerated
developmental kinetics upon reduced phf6 or notch1 activation. In summary, our work
reveals that appropriate control of PHF6 expression is important for normal human
hematopoiesis and provides clues towards the role of PHF6 in T-ALL development.
Keywords: hematopoiesis, PHF6, NOTCH, zebrafish, T cell development
INTRODUCTION
Hematopoietic lineage development is hierarchically organized and involves highly dynamic
processes in which hematopoietic stem cells balance between self-renewal and differentiation to
generate a wide variety of blood cell types. This process is tightly controlled by various key
transcriptional regulators that integrate environmental cues, such as growth factors and cell-
intrinsic signals, including epigenetic modifications, to dictate the developmental outcome (Dege
and Hagman, 2014; De Obaldia and Bhandoola, 2015; Rothenberg et al., 2016). Many of these
developmental genes have been identified through the study of loss- or gain-of-function genetic
alterations in hematopoietic malignancies.
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The NOTCH signaling pathway is a clear example of
a molecular axis that plays a central role in both normal
and malignant hematopoiesis. Constitutive NOTCH1 signaling,
mainly through NOTCH1 activating mutations or mutations
affecting NOTCH1 pathway regulators, are observed in over
60% of all T cell acute lymphoblastic leukemia (T-ALL) cases
(Weng et al., 2004). Further studies subsequently also showed
the crucial role of NOTCH1 signaling in normal hematopoiesis
with primarily a vital role in normal T cell development (Radtke
et al., 1999; Yashiro-Ohtani et al., 2010). NOTCH1 signaling
also regulates hematopoietic stem cell (HSC) emergence (Pajcini
et al., 2011; Gama-Norton et al., 2015) as well as myeloid (De
Obaldia et al., 2013), erythroid (Oh et al., 2013) and lymphoid
differentiation (Radtke et al., 2013), highlighting its central
regulatory role in hematopoiesis. Over the last decade, multiple
factors that work in crosstalk with the NOTCH1 pathway to
tightly control normal T cell development have been described
and are still a major subject of study, as exemplified by our
recent work on the role of GATA3 in the process of T-lineage
commitment (Van de Walle et al., 2016).
In addition to NOTCH1, PHF6 is amongst the most frequently
affected genes in T-ALL due to loss-of-function mutations (Van
Vlierberghe et al., 2010). PHF6, which contains 2 imperfect PHD
domains, is considered to be an epigenetic reader molecule (Liu
et al., 2015; Todd et al., 2015), exerting its function at least
partly through its interaction with components of the NuRD
complex such as CHD4 and RBBP7 (Todd and Picketts, 2012). In
addition, it affects rRNA synthesis through binding UBF (Wang
et al., 2013) and regulates transcription by interacting with the
PAF1 transcriptional elongation complex (Zhang et al., 2013).
Intriguingly, recent analyses of larger T-ALL cohorts indicate that
PHF6 inactivation predominantly occurs in NOTCH1 activated
T-ALLs, suggesting a functional connection between both genes.
This was confirmed by the observation of accelerated leukemia
development upon introducing PHF6 mutations in NOTCH1-
driven murine T-ALL models, partly by elevating the leukemia
stem cell numbers (Hsu et al., 2019; Wendorff et al., 2019).
PHF6 mutations have not been observed thus far in non-
hematopoietic malignancies, suggesting a crucial role in normal
hematopoiesis. It is already shown that loss of PHF6 expression
in B-ALL cells can induce a partial switch toward the T cell
lineage (Soto-Feliciano et al., 2017) and additional recent data
support a role for PHF6 in murine hematopoietic stem and
progenitor cell homeostasis (McRae et al., 2019) and renewal
(Miyagi et al., 2019).
In order to further scrutinize potential roles of PHF6
more broadly during normal human hematopoiesis, we
studied the effects of PHF6 knockdown in normal human
hematopoietic precursor cells (HPCs) and validated our
observed phenotypes in a phf6 knock-out zebrafish model
(Moore et al., 2012). We show dynamic regulation of PHF6
during normal human hematopoiesis and the requirement of
controlled PHF6 expression to ensure normal hematopoietic
lineage differentiation. Furthermore, we show that PHF6
knockdown during T cell development in human in vitro and
in zebrafish in vivo modulates NOTCH1 expression and its
downstream signaling activity, further supporting a functional




Cord blood (CB), peripheral blood (PBL) and pediatric thymus
samples were obtained and used according to the guidelines of
the Medical Ethical Commission of Ghent University Hospital
(Belgium). After lymphoprep density gradient of CB and
PBL, mononuclear cells were isolated and used for further
purifications. PBL-derived mononuclear cells were labeled with
CD3-efluor780 (eBioscience), CD14-FITC (BD Biosciences),
CD19-PE (Miltenyi Biotec) and CD56-APC (BD Biosciences) to
sort for T cells, monocytes, B cells and NK cells, respectively. CB-
derived CD34+ cells were purified using magnetic activated cell
sorting beads (MACS, Miltenyi Biotec). Subsequently, enriched
cord blood CD34+ cells were labeled with CD34-PE (Miltenyi
Biotec), CD3-APC, CD14-APC, CD19-APC and CD56-APC
(APC antibodies from BD Biosciences) to sort CD34+Lin− cells
with a FACSAriaII (BDIS) (Waegemans et al., 2014). Thymus-
derived CD34+ T cell precursors were purified using MACS as
described (Van de Walle et al., 2013). Purity of the sorted cells
was checked on a LSRII (BDIS) and was always >98%.
Viral Constructs – Transduction of HPCs
and Jurkat T-ALL Cells
pLKO.1-puroR (SHC002, control shRNA) and
TRCN0000020122 (SHC20122, PHF6 shRNA) lentiviral
vectors were purchased from Sigma in which the puromycin
resistance gene was replaced with a PCR-amplified EGFP cDNA
using BamHI and KpnI restriction sites. Infectious lentivirus
was produced by jetPEI (polyplus transfectionTM) mediated
transfection of the 293FT cell line with either pLKO.1-SHC002-
EGFP or pLK0.1-SHC20122-EGFP, in conjunction of the
pCMV-VSV-G (envelope) and p8.91 (packaging) constructs.
The virus supernatant was harvested 2 and 3 days after
transfection. Lentiviral transduction of HPCs was performed on
sorted CD34+Lin− CB cells or CD34+ thymocytes, previously
cultured in complete IMDM medium containing 10% FCS
and supplemented with TPO (20 ng/ml), SCF (100 ng/ml) and
FLT3-L (100 ng/ml) or SCF (10 ng/ml) and IL-7 (10 ng/ml),
respectively, for 2 days (cord blood) or one day (thymocytes).
48 h after transduction, cells were harvested and sorted for
EGFP+ transduced cells. Jurkat T-ALL lymphoblasts were
transduced with the same control or PHF6 shRNA constructs
after seeding at a density of 0.5 × 10e6 cells/ml in complete
RPMI medium containing 10% FCS. Transduced Jurkat cells
were harvested 96 h post-transduction for RNA-isolation.
OP9 Cocultures and Flow Cytometry
Transduced and sorted CD34+Lin−EGFP+ CB cells or
CD34+EGFP+ thymocytes were seeded in a 24 well plate
containing a confluent layer of either OP9 control stromal
cells expressing GFP (OP9-GFP) or Delta-like-ligand1 (DLL1)
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or Delta-like-ligand4 (DLL4) expressing OP9 stromal cells
(OP9-DLL1 or OP9-DLL4 respectively). All cocultures were
performed in α-MEM media (Invitrogen) supplemented with
20% heat-inactivated FCS plus 100 U/ml penicillin, 100 µg/ml
streptomycin and 2 mM L-glutamin (all from Invitrogen). To
induce and support T and B cell differentiation, cultures were
performed in the presence of SCF, IL-7 and FLT3-L (all 5 ng/ml)
on OP9-DLL1 and OP9-GFP, respectively. For the generation of
NK cells, OP9-GFP cocultures were supplemented with 10 ng/ml
IL-15 in addition to SCF, IL-7 and FLT3-L (all 5 ng/ml). For
myeloid differentiation, cocultures were executed with SCF, TPO,
FLT3-L (all 20 ng/ml) and G-CSF and GM-CSF (both 10 ng/ml).
For red blood cell differentiation, cultures were supplemented
with SCF, EPO and TPO (50 ng/ml). For y-secretase inhibition
(GSI) experiments, 1 µM of 7 N-[N-(3,5- difluorophenyl-L-
alanyl)]-S-phenyl-glycine t-butyl ester (DAPT; Peptides Inter-
national, Louisville, KY, United States), diluted in dimethyl
sulfoxide (DMSO), was added to the co-cultures and an equal
concentration of DMSO was used as control. Cocultures were
performed at 37◦C in a humidified atmosphere containing 7%
(v/v) CO2 in air. Cocultures were harvested by forceful pipetting
at indicated time points. Obtained cell suspensions were blocked
with anti-mouse FcRγII/III (clone 2.4.G2) and human IgG
(Fcblock, Miltenyi) to avoid non-specific binding, subsequently
stained with combinations of anti-human monoclonal antibodies
(BDIS, eBioscience, Biolegend and Miltenyi) and analyzed on a
LSRII (BDIS).
Gene Expression Profiling and Gene Set
Enrichment Analysis
RNA samples were profiled on a custom designed Agilent micro-
array covering all protein coding genes [33,128 mRNA probes,
Human Sureprint G3 8 × 60k micro-arrays (Agilent)] and
12,000 lncRNAs (23,042 unique lncRNA probes) (Volders et al.,
2013). The expression datasets generated are deposited in the
Gene Expression Omnibus database (GEO) (GSE85373). See
Supplementary Methods for further details.
GSI Treatment in Zebrafish Embryo’s and
Imaging
Tg(rag2:GFP) embryos were treated from 3 to 6 days post-
fertilization (dpf) with 8 µM or 2 µM GSI in E3 media (1X
E3 + 0,0001% methylene blue). DMSO was used as control
treatment. The embryos were held in a 24 well plate with a
maximum of 10 embryos per well and put in fresh E3 media
and GSI treatment on a daily basis. Compound treatment was
started 3 dpf until day 6 to avoid lethal side-effects during
early embryogenesis. For the phf6 zebrafish studies, Tg(rag2:GFP)
zebrafish were mated with either wild-type AB zebrafish or
phf6c.165del10/c.165del10 zebrafish. Thymus development and size
were monitored and measured from 4 dpf, when rag2 expression
commences (Ma et al., 2013), until 6 dpf. The treated embryos
were screened for GFP signal by the use of a Nikon SMZ18
microscope. Thymus size was measured with the NIS-Elements
Analysis software. During this procedure, the zebrafish were
anesthetized with 0.016% tricaine.
RESULTS
PHF6 Is Dynamically Expressed During
Human Hematopoiesis
To explore the role of PHF6 in normal human hematopoietic
lineage differentiation, we first measured PHF6 gene expression
levels in different human blood cell types (Figure 1A). PHF6 is
expressed in all hematopoietic subpopulations with prominent
high expression levels in CD34+ hematopoietic precursor cells
(HPCs) and CD19+ B cells, whereas CD3+ T cells showed lower
expression. CD56+ NK cells and particularly CD14+ monocytes
displayed the lowest PHF6 expression levels, in agreement
with publicly available data from Bloodspot (bloodspot.eu)
(Figure 1B). Furthermore, published expression data during
human lymphopoiesis (Figure 1C; Casero et al., 2015) showed
a decrease in PHF6 expression in early B cell precursors
compared to in CD34+CD38− HPCs but an increase during
early T-lymphoid development. The latter was also observed
in in vitro generated T cell precursors on OP9-DLL1 stromal
layers, indicating that this in vitro model recapitulates PHF6
expression dynamics that occur in vivo (Figure 1D; Canté-
Barrett et al., 2017). Thus, PHF6 is dynamically expressed during
human hematopoiesis which suggests regulatory functions
during hematopoietic stem cell differentiation.
Reduced PHF6 Expression Impacts on
Erythroid and Lymphoid Differentiation
To assess the impact of PHF6 loss on the differentiation potential
of human HPCs, we first optimized stable PHF6 knockdown in
Jurkat T-ALL cells using lentiviral gene transfer (Supplementary
Figure 1a) and this confirmed strong PHF6 downregulation
both at the mRNA (left) and protein level (right) which was
also observed at the mRNA level in cord blood (CB)-derived
CD34+ HPCs (Supplementary Figure 1b). Next, PHF6 shRNA
transduced CD34+Lin− CB HPCs were induced to differentiate
in vitro in the presence of lineage-specific cytokines using well-
established OP9 cocultures (Van de Walle et al., 2011). This
revealed marked effects of reduced PHF6 levels on human
hematopoiesis. In OP9-GFP cultures conditions that permit B
cell development, we noticed a significant increase in both the
frequency and absolute number (Figure 2A) of CD19+HLA-
DR+ B cells upon PHF6 knockdown compared to the control
condition. In contrast, reduced PHF6 expression in CD34+ CB
HPCs that were cultured in NK-lineage conditions significantly
decreased the generation of CD56+CD5− NK cells compared
to control transduced cells, both in frequency and absolute
numbers (Figure 2B). In myeloid culture conditions (Klinakis
et al., 2011; Van de Walle et al., 2011), the impact of PHF6
knockdown on monocyte differentiation was modest. A slight but
consistent increase in the frequency of CD14+CD4+ monocytes
was observed, but no significant difference was seen in absolute
cell counts (Figure 2C). Given the high PHF6 expression
in MEPs (Figure 1B), we also evaluated the effect of PHF6
downregulation on the differentiation of CD34+ CB HPCs
toward erythrocytes and observed a significant decrease in the
generation of CD71+CD45− red blood cells compared to control
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FIGURE 1 | Dynamic PHF6 expression during human hematopoiesis. Relative expression of PHF6 in various hematopoietic cell types: (A) in sorted subsets of
human hematopoietic cell lineages, data shows the average of 3–4 independent samples and error bars indicate SEM; (B) adapted from Bloodspot (bloodspot.eu);
(C) during human lymphopoiesis (Casero et al., 2015) or (D) during early T lymphoid development in vitro (Canté-Barrett et al., 2017).
transduced precursors (Figure 2D). On OP9-DLL1 stromal cells
that permit induction of T-lineage differentiation, a small but
consistent reduction in the most immature CD34+CD7+ T cell
precursors was observed upon PHF6 knockdown which resulted
in a significant reduction in their absolute numbers compared to
the control (Figure 2E).
To understand the potential underlying mechanisms of
these developmental changes, we performed gene expression
profiling in shPHF6 transduced CD34+ progenitor cells that
were short-term cultured on OP9-GFP and applied gene set
enrichment analysis (GSEA) based on the resulting expression
signatures and publically available transcriptional profiles of
sorted populations of different human hematopoietic cell types
(Van de Walle et al., 2013). Consistent with the preferential
differentiation toward B lymphocytes of PHF6-deficient HPCs,
B cell lineage genes (including VPREB3, RAG1 and CD200)
were significantly enriched in the set of genes upregulated upon
PHF6 knockdown compared to myeloid (Figure 3A) or NK
cell signatures (Figure 3B). However, despite the reduction in
red blood cell development, an enrichment in genes expressed
higher in erythrocytes compared to HSCs was observed upon
PHF6 knockdown (Figure 3C), but not for genes that are higher
expressed in MEPs compared to HSCs (Figure 3D). Taken
together, our data indicates that PHF6 levels modulate human
lymphoid development and suggests that loss of PHF6 expression
results in premature induction of erythroid genes that hampers
their development.
PHF6 Modulates NOTCH1 Expression
and Its Downstream Signaling Activity in
Human T-Lineage Cells
Given the central role of NOTCH1 during early T cell
development and the frequent co-occurrence of activating
NOTCH1 and loss-of-function PHF6 mutations in T-ALL,
we evaluated the effects of PHF6 knockdown on T cell
development in more detail. Indeed, the increase in B-lineage
differentiation (Figure 2A) and reduction in early T-lymphoid
development (Figure 2E) are suggestive for reduced Notch1
activity upon PHF6 knockdown. Therefore, we initiated OP9-
DLL1 cocultures with control or PHF6 shRNA transduced
human CD34+ thymocytes and observed remarkable accelerated
differentiation toward the CD4+CD8+ double positive (DP)
differentiation stage (Figure 4A). Interestingly, such enhanced
DP differentiation was previously also observed in CD34+
human thymocytes upon attenuation of NOTCH activity (Van
de Walle et al., 2013, 2009), indicating that PHF6 knockdown
may indeed negatively impact NOTCH1 signaling. Indeed,
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FIGURE 2 | PHF6 is essential for normal hematopoietic differentiation. (A–D) (up) Dot plots show flow cytometry analysis of control and PHF6 shRNA transduced
cord blood CD34+Lin− precursors in OP9-GFP cocultures, showing the development of (A) CD19+HLA-DR+ B-lineage cells after 28 days of coculture,
(B) CD56 + CD5- NK cells after 21 days of coculture, (C) CD14+ CD4+ monocytes after 14 days of coculture and (D) CD45+ CD71− erythrocytes after 7 days of
coculture. Bar plots (down) show absolute numbers of corresponding populations. (E) (up) Dot plots show flow cytometry analysis of control and PHF6 shRNA
transduced cord blood CD34+Lin− precursors in OP9-DLL1 cocultures, showing the development of CD34+CD7+ T cell precursors after 7 days of coculture. Bar
plot (down) shows absolute numbers of the corresponding population. Data shows average of 5–7 independent experiments and error bars indicate SEM. *P < 0.05
(non-parametric paired Wilcoxon test).
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FIGURE 3 | PHF6 controls the expression of hematopoietic lineage genes. (A,B) Gene Set Enrichment Analysis shows that an early B cell gene signature is
significantly enriched at expense of (A) a myeloid gene signature (GSE24759) and (B) NK cell (CD56+CD16+CD3−) gene signature (GSE24759) in short-term
cultures of CD34+ progenitors on an OP9-GFP stromal feeder layer with stable PHF6 knockdown (GSE85373). (C,D) Gene Set Enrichment Analysis shows that an
erythrocyte gene signature (C) but not a MEP gene signature (D) is significantly enriched at expense of a HSCs gene signature (GSE24759) in short-term cultures of
CD34+ progenitors on an OP9-GFP stromal feeder layer with stable PHF6 knockdown.
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FIGURE 4 | PHF6 modulates Notch1 expression and its downstream signaling activity. (A) (left) Flow cytometry analysis of control and PHF6 shRNA transduced
CD34+ thymocytes in OP9-DLL1 cocultures in the presence of IL7, SCF and FLT3L, showing the development of CD4+CD8β+ DP thymocytes after 21 days of
coculture. (right) Bar plot showing the frequency of CD4+CD8β+ DP thymocytes, generated in the corresponding cultures. Data shows the average of 4 independent
experiments and errors bars show SEM. *P < 0.05 (paired t-test) (B) Normalized NOTCH1 and DTX1 expression in Jurkat cells (left) and CB-derived CD34+ HPCs
(right) following control or PHF6 shRNA transduction as indicated. Data shows the average expression in 3 independent samples and error bars indicate SEM.
consistent with the PHF6-mediated regulation of NOTCH1
expression in B-ALL cells (Meacham et al., 2015), we also
observed reduced NOTCH1 expression upon stable PHF6
knockdown in Jurkat leukemic T cells, as well as in OP9-DLL1
cocultured human CD34+ HPCs (Figure 4B). This also affected
downstream NOTCH1 signaling as shown by the concomitant
reduced expression of the direct NOTCH1 target gene DTX1
(Figure 4B). In addition we found a significant enrichment
of genes reported as NOTCH1-dependent in CD34+ T cell
progenitors (Durinck et al., 2014) in the set of downregulated
genes upon shPHF6 knockdown in Jurkat cells (Figure 5A)
and in CD34+ T cell precursors (Figure 5B). Importantly,
these included canonical target genes that are NOTCH1-
dependent during early stages of human T cell development
such as DTX1 and HES4 (Supplementary Table 1). These
observations were confirmed independently in ALL-SILL T-ALL
lymphoblasts. To this end, we transiently downregulated PHF6
by means of siRNA-mediated transfection (Supplementary
Figure 2a), resulting in a downregulation of NOTCH1 and
DTX1 expression (Supplementary Figures 2b,c). As shown by
GSEA, also NOTCH1 downstream target genes are significantly
downregulated upon PHF6 knockdown (Supplementary
Figure 2d). Overall, these finding establish that loss of PHF6
not only reduces NOTCH1 expression itself, but that it also
functionally affects NOTCH1 downstream signaling.
PHF6 Levels Modulate NOTCH Activity
During Human T Cell Development
To further unravel the connection between PHF6 and NOTCH1
during thymopoiesis, we compared the effects of modulated
PHF6 expression and altered NOTCH1 signaling activity in
more detail by stable knockdown of PHF6 and pharmacological
inhibition of Notch signaling using a γ-secretase inhibitor
(GSI), respectively. Here, and to confirm our OP9-DLL1
derived results, we used OP9-DLL4 cocultures to provide
the physiological NOTCH1 ligand. Similar as on OP9-DLL1
cocultures, thymocytes with reduced PHF6 levels progressed
significantly faster toward the double positive (CD4+CD8+,
DP) stage of T cell development in comparison to control
transduced cells after 18 days of culture (Figure 6A). These
increased numbers of DP cells are most likely to arise due
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FIGURE 5 | PHF6 modulates the Notch1 gene signature. Gene Set Enrichment Analysis shows that the top-500 significantly induced genes in CB CD34+
progenitors cultured on an OP9-DLL1 stromal feeder layer in comparison to OP9-GFP cocultures are significantly enriched in the set of genes that are downregulated
upon stable knockdown of PHF6 in panel (A) Jurkat T-ALL cells (GSE85373) and (B) CB CD34+ cells cultured on an OP9-DLL1 stromal feeder layer (GSE85373).
to a general accelerated differentiation, given that this rise in
DP frequency and absolute counts upon PHF6 knockdown
compared to controls is consistently, also already observed at
earlier time points of 6 and 14 days of coculture (Supplementary
Figures 3a,b). Furthermore, a comparable acceleration towards
this DP stage was also observed in control transduced T cell
precursors exposed to GSI both in frequency and absolute
cell counts (Figure 6A and Supplementary Figures 3a,b),
in agreement with previous findings (Van de Walle et al.,
2009). Consistent with this DP phenotype and the differential
requirement for NOTCH signaling activity (Van de Walle et al.,
2009, 2013), loss of PHF6 skewed differentiation of human
T cell precursors toward TCR-αβ T cells (Figure 6B) at the
expense of TCR-γδ T cell development (Figure 6C) both in
frequencies as in absolute counts respectively, further supporting
a functional parallel between NOTCH1 and PHF6 during normal
T cell development.
The Phf6-Notch Regulatory Axis During
Early T Cell Development Is Conserved
Between Zebrafish and Human
Given the important differences in the role of NOTCH
signaling during early mouse and human T cell development
(Taghon et al., 2012), we evaluated whether zebrafish could
be a more appropriate model to confirm our in vitro human
PHF6 data in an in vivo context. Moreover, the transparent
embryos of this model organism additionally allow to visualize
developmental processes.
Sequence alignment of the Phf6 protein for human, zebrafish,
mouse, chicken, chimpanzee and rat revealed a high degree of
amino acid sequence conservation across these different species
(Supplementary Figure 4a). Blasting (NCBI protein blast) the
human PHF6 protein sequence against that of zebrafish resulted
in an overall 71% peptide identity with an even higher 81.1
and 92.5% identity for both functional plant homeodomain
zinc fingers 1 and 2 (PHD1 & PHD2), thus indicating a high
degree of functional conservation. In human, the highest PHF6
expression is observed in the thymus, ovary and thyroid tissues
while a moderate expression is detected in spleen, testis and
adipose tissue (Van Vlierberghe et al., 2010). In zebrafish, we
observed phf6 expression in all dissected organs with the highest
expression in ovary, testis, kidney and thymus, thus closely
resembling the human expression pattern (Supplementary
Figure 4b). The expression of phf6 in the zebrafish kidney is
particularly interesting since all hematopoietic cells types, except
for thymocytes, are found in this organ (Jing and Zon, 2011;
Jagannathan-Bogdan and Zon, 2013). Thus, in addition to high
structural conservation, these findings also suggest functional
conservation of PHF6 in zebrafish and human.
To validate such functional similarities between human and
zebrafish regarding NOTCH signaling, Tg(rag2-GFP) fish were
treated with either low (2 µM, n = 44) or high doses (8 µM,
n = 36) of GSI compared to the DMSO (n = 40) solvent
control. Tg(rag2-GFP) zebrafish were used because this approach
allows visualization of the emerging thymus through the rag2-
expressing GFP+ thymocytes. T cell development was monitored,
and thymus size measured from 4 days post fertilization (dpf)
until 6 dpf. Consistent with our findings in vitro, zebrafish treated
with 2 µM GSI displayed accelerated T cell maturation compared
to the control treated fish. At 4 dpf 59% (2 µM) and 72% (8 µM)
GSI-treated fish showed GFP signal in the thymus while only
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FIGURE 6 | Loss of PHF6 mimics reduced Notch activity during human T cell development. (A–C) (left) Flow cytometry analysis and (right) absolute cell counts of
control versus PHF6 shRNA transduced or DMSO versus 1 µM GSI treated CD34+ thymocytes in OP9-DLL1 cocultures showing (A) the development of
CD4+CD8β+ DP thymocytes after 18 days of coculture, (B) the development of CD3+TCRαβ+ thymocytes after 25 days of coculture and (C) the development of
CD3+TCRγδ+ thymocytes after 25 days of coculture. Data shows the average of 3 independent experiments and errors bars show SEM. *P < 0.05 (paired t-test).
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15% of the DMSO control treated fish had visible GFP expression
in the thymus (Figure 7A and Supplementary Tables 2, 3).
Applying a higher dose of GSI (8 µM) resulted initially in
faster T cell developmental kinetics at 4 dpf, but significantly
reduced the thymus size in later stages of development at 6 dpf,
consistent with our human data (Taghon et al., 2012) (Figure 6A
and Supplementary Tables 2, 3). Collectively, the zebrafish data
support conservation of Phf6 function and of Notch signaling
during early T cell development between zebrafish and human.
Phf6 Controls Notch1 Expression and T
Cell Development in vivo
To assess a role for Phf6 in T cell development in vivo, we
took advantage of an available phf6 TALEN mutated zebrafish
line (Moore et al., 2012; Loontiens et al., 2020). Specifically,
phf6 mutations were created in exon 2 and resulted in a 10
nucleotide deletion and premature stop codon (Supplementary
Figure 4c). The effect of the 10 bp deletion in the phf6
gene was analyzed by means of RT-qPCR, and a significant
downregulation of phf6 levels was seen in phf6 heterozygote fish
compared to wildtype, mimicking PHF6 downregulation seen
upon knockdown in vitro (Supplementary Figure 4d). We then
further investigated the role of Phf6 in thymopoiesis in vivo
by crossing transgenic Tg(rag2:GFP) zebrafish with either AB
wildtype or phf6c.165del10/c.165del10 mutant zebrafish. The resulting
offspring were kept separately at 4 dpf and thymus development
was monitored until 6 dpf (Figures 7B,C). At 4 dpf, significantly
more phf6c.165del10/+ mutant fish showed GFP expression in
the thymus region compared to the AB wild type (62 versus
14%, respectively, Figures 7B,C and Supplementary Table 4).
By 5 dpf, almost all (96%) of the phf6c.165del10/+ mutant fish
displayed detectable rag2-GFP expression while the wild type
fish needed 6 days to reach such frequencies (Figures 7B,C and
Supplementary Table 4). Independent morpholino experiments
confirmed these Phf6-mediated effects on T cell development
(Supplementary Figure 4e). Quantification of thymus size
revealed a significant larger thymus at 4 and 5 dpf for
phf6c.165del10/+mutant compared to wildtype fish (Figure 7B and
Supplementary Table 4), indicating that phf6 downregulation
results in initial faster kinetics of T cell development. In
agreement, RT-qPCR analysis of sorted thymocytes (Loontiens
et al., 2019) showed a downregulation of notch1a expression
in phf6c.165del10/+ embryos compared to thymocytes from
wild type embryo’s (Figure 7D), as well as in thymocytes of
adult phf6c.165del10/+ versus wild type zebrafish (Figure 7D).
Collectively, these in vivo findings confirm that Phf6 modulates
Notch1 expression during thymopoiesis and that loss of Phf6
mimics the effects of reduced Notch1 expression on thymopoiesis
in zebrafish, similarly as observed in human.
DISCUSSION
Despite the fact that loss-of-function PHF6 mutations are
amongst the most frequent genetic alterations in T-ALL, the
role of PHF6 in normal and malignant hematopoiesis is
functionally still uncharacterized. Here, we show that PHF6
is dynamically expressed during hematopoiesis and that PHF6
levels functionally impact normal human hematopoietic lineage
differentiation. Consistent with the strong association between
loss-of-function PHF6 mutations and activating NOTCH1
mutations in T-ALL (Wang et al., 2011; Li et al., 2016), we
reveal that NOTCH1 expression and signaling is dependent
on PHF6 expression during normal T cell development. We
observed similar developmental effects for both PHF6 and
Notch activity in our in vitro PHF6 loss-of-function experiments
for human T cell development. In addition, we independently
confirmed these findings in vivo using a pfh6 knock-out
zebrafish model.
Importantly, the findings from this manuscript are consistent
with our previous work on the role of Notch signaling during
human T cell development. The differentiation of human
CD34+ thymocytes into DP and TCR αβ-lineage thymocytes
is indeed dependent on a reduction of Notch signaling activity
in the OP9-DLL1 (or OP9-DLL4) coculture system that can be
triggered by adding low dosages of GSI (Taghon et al., 2012).
In vivo, this reduction in Notch activation is equally important
(Durinck et al., 2014), as also illustrated by the induction of
T-ALL upon continuous Notch activation (Ferrando, 2009), and
this could be controlled through migration within the thymic
microenvironment to regions with a reduced availability of
Notch ligands (Van de Walle et al., 2013). Also the reduction
in TCRγδ T cell development that occurs upon knockdown
of PHF6 corresponds with the strong Notch requirement for
their development (Van de Walle et al., 2009, 2013). We
recently illustrated that Notch activity during early human T cell
development is also dependent on GATA3 activity that mediates
downregulation of DTX1 (Van de Walle et al., 2016), consistent
with the impact of reduced PHF6 expression on NOTCH1
and DTX1 expression. Intriguingly, besides a direct connection
between PHF6 and NOTCH1 as shown by the binding of PHF6
to the transcription start site locus of NOTCH1 in Jurkat cells
(Meacham et al., 2015), recent data have shown that loss of PHF6
function also increases chromatin accessibility at the GATA3
locus (Soto-Feliciano et al., 2017), suggesting that the observed
effects of PHF6 knockdown on T cell development may be
mediated by several transcriptional mediators in addition to
changes in NOTCH1.
While it remains to be determined if PHF6 has a similar
role in mice, we choose not to use this organism for in vivo
experiments given the significant differences between mouse and
human regarding the Notch signaling requirements during T
cell development (Taghon et al., 2012). Indeed, while Notch
signaling is important in both mouse and human to induce T-cell
lineage specification in multipotent hematopoietic precursors
(Wilson et al., 2001; Van de Walle et al., 2009), the subsequent
stages of T cell development show altered Notch signaling
requirements in both species. While differentiation of specified
T cell precursors into DP TCR-αβ lineage cells is highly
Notch-dependent in mice (Ciofani et al., 2006; Taghon et al.,
2006), this developmental process occurs much more efficient
in human when Notch signaling is reduced (Van de Walle
et al., 2009, 2013; Dolens et al., 2020). In contrast, TCRγδ
T cell development is highly Notch-dependent in human
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FIGURE 7 | phf6 downregulation accelerates T cell development in vivo. (A) Box plot showing thymus size (µm2) at 4, 5, and 6 days post-fertilization (dpf) based on
GFP signal of wild type (AB) fish treated with 2 or 8 µM of gamma-secretase inhibitor (GSI) or DSMO as control treatment. Details on these results are provided in
Supplementary Table 2 and statistical analysis is shown in Supplementary Table 3, ∗P < 0.05 (Wilcoxon rank sum test). (B) Boxplot showing thymus size (µm2)
of wild type (AB) and phf6c.165del10/+ heterozygous embryos from 4 until 6 dpf based on rag2-GFP signal quantification. ∗P < 0.05 (Wilcoxon rank sum test,
Supplementary Table 4). (C) Representative image of thymus visualization used for quantification of data as shown in panel (A). Original magnification X30. Circle
with white dashed line indicates emerging thymus. (D) Average normalized notch1a and phf6 expression in sorted T cells of 4 replicates of 100 pooled wild type (AB)
and phf6c.165del10/+ embryo’s on 6dp (left) and of 3 replicates of 6 pooled wildtype and 6 pooled phf6c.165del10/+ adult zebrafish (right). Error bars indicate SEM,
∗P < 0.05 (unpaired T-test).
(Van de Walle et al., 2009, 2013; Dolens et al., 2020) but less in
mouse (Ciofani et al., 2006; Taghon et al., 2006). In addition,
genetic studies in zebrafish are increasingly used to study human
genetic aberrations, as illustrated for BCL11B mutations during
T cell development (Punwani et al., 2016). The findings in this
manuscript further support the importance of zebrafish as a
model to study normal hematopoiesis and particularly T cell
development (Zhang and Wiest, 2016) as both the effects of
PHF6 knockdown and of reduced NOTCH signaling activation
on human T cell development were confirmed in vivo. The
possibility to image T cell development in embryos also allows to
perform kinetic studies in vivo, which is also a significant strength
of in vitro studies, since they allow to reveal developmental
abnormalities that may be obscured in adult organisms as a result
of homeostatic expansion mechanisms. However, in zebrafish,
thymopoiesis consists out of two waves, with the first wave
starting from 3 dpf and mainly producing αβ-CD4 T cells, while
the second wave commences at 8 dpf and gives rise to αβ-
CD4, αβ-CD8 and γδ T cells (Tian et al., 2017). This study
suggests that both Phf6 and Notch influence this first wave of
thymopoiesis, producing the αβ-CD4 T cells. The enhanced TCR-
αβ differentiation at the expense of the γδ-lineage could not be
assessed by our experimental timeframe and set up. Additional
studies are required to fully explore to what extent hematopoiesis
is conserved between human and zebrafish as compared to mice
(Mestas and Hughes, 2004; Payne and Crooks, 2007).
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The observed effect of PHF6 knockdown on B cell
development is also in line with reduced NOTCH1 signaling
activity since B-lineage differentiation is extremely sensitive to
small dosages of signaling activity. Although these experiments
were performed on OP9-GFP stromal cells in the absence of
a NOTCH ligand that is sufficiently strong to induce T cell
development and to fully inhibit B cell development, OP9 cells
express significant levels of Jagged-1 and -2 (Schmitt and Zúñiga-
Pflücker, 2002) that can partially hamper B cell development
(Van de Walle et al., 2011). However, given the significant
increase in B cell signature genes upon PHF6 knockdown, it is
possible that PHF6 directly regulates at least some of these genes
independent of Notch signaling activity, consistent with its role
as an epigenetic regulator (Soto-Feliciano et al., 2017). Such a
direct regulatory role for PHF6 may also be required for the
expression of NK-lineage genes that are not Notch-dependent
in all circumstances, such as DTX1 and TBX21 (Rankin et al.,
2013), although we have also demonstrated that Notch signaling
enhances NK cell development (De Smedt et al., 2007). While we
mainly focused on lymphocyte development, the lack of effect
on monocytic differentiation upon PHF6 knockdown and the
low expression that is observed in ex vivo isolated monocytes
suggests that PHF6 is mainly involved in regulating lymphocyte
development. Nevertheless, we also observed a clear phenotype
with respect to erythroid development. Although the impact
of reduced PHF6 expression was apparently inconsistent with
respect to the reduced development of erythrocytes compared to
the increased expression of red blood cell genes, the premature
expression of these genes in HPCs may hamper the appropriate
differentiation of these precursors toward erythrocytes given that
genes from the intermediate MEP stage were not altered upon
PHF6 knockdown. Intriguingly, also Notch activation has been
implicated in erythroid development in mice (Oh et al., 2013).
In the context of leukemia, PHF6 has been suggested to
act as an oncogene in B-ALL (Meacham et al., 2015; Soto-
Feliciano et al., 2017). Although the enhanced differentiation
of CD34+ HPCs towards the B cell lineage upon PHF6
knockdown might seem inconsistent with such an oncogenic
role, it is well-established that context-specific roles may alter
protein function and/or requirement. This has for instance
been clearly illustrated for Notch activation that strongly
antagonizes early B cell development (Wilson et al., 2001), yet,
Notch2 activation is later essential within the B cell lineage
for marginal zone B cell development (Saito et al., 2003).
Moreover, activating Notch mutations have been described in
B cell malignancies (Chiang et al., 2016). In T-ALL, PHF6
and NOTCH1 are considered to act as tumor suppressor and
oncogenes, respectively (Ferrando, 2009; Van Vlierberghe et al.,
2010). Therefore, our finding that PHF6 knockdown attenuates
NOTCH1 activity may seem counterintuitive in the context of
T-ALL oncogenesis. However, in T-ALL patients that harbor loss-
of-function PHF6 mutations, there is a significant association
with activating mutations in NOTCH1 or its downstream target
IL7R (Wang et al., 2011; Vicente et al., 2015; Li et al., 2016),
indicating that reduced PHF6 function triggers the cells to
compensate for the reduced activity of these critical T-lineage
proliferation/survival pathways.
In conclusion, our results reveal an important regulatory role
for PHF6 during normal hematopoiesis and provide novel clues
towards the tumor suppressor role of PHF6 in T-ALL.
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